These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4919426)

  • 1. Rate of antigen catabolism and immunogenicity of [131-I]BGG in mice. I. Action of mycobacterial adjuvants.
    Stark JM
    Immunology; 1970 Sep; 19(3):449-56. PubMed ID: 4919426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate of antigen catabolism and immunogenicity of [131-I]BGG in mice. II. Immunogenicity of [131-I]BGG and adjuvant action after alteration of the metabolic rate by various means.
    Stark JM
    Immunology; 1970 Sep; 19(3):457-64. PubMed ID: 5471829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adjuvant effect of microbial products on the immune response.
    White RG
    Annu Rev Microbiol; 1976; 30():579-600. PubMed ID: 185941
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.
    Azuma I; Kanetsuna F; Taniyama T; Yamamura Y; Hori M
    Biken J; 1975 Mar; 18(1):1-13. PubMed ID: 807194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation.
    Paik TH; Lee JS; Kim KH; Yang CS; Jo EK; Song CH
    Vaccine; 2010 Nov; 28(50):7873-80. PubMed ID: 20937311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of delayed hypersensitivity to acquired antituberculous immunity. II. Effect of adjuvant on the allergenicity and immunogenicity of heat-killed tubercle bacilli.
    Collins FM; Mackaness GB
    Cell Immunol; 1970 Sep; 1(3):266-75. PubMed ID: 5002230
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Factors controlling the adjuvant or immunosuppressive action of antigens in complete Freund-type mixtures.
    White RG
    Ann Sclavo; 1971; 13(6):821-36. PubMed ID: 5005894
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenicity of bovine serum albumin and its oligopolymers in CBA mice.
    Stark JM; Spitznagel JK
    J Immunol; 1972 Mar; 108(3):800-6. PubMed ID: 5011757
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of cell walls of Mycobacterium bovis strain BCG administered by various routes and in different adjuvants in protecting mice against airborne infection with Mycobacterium tuberculosis strain H37Rv.
    Anacker RL; Barclay WR; Brehmer W; Goode G; List RH; Ribi E; Tarmina DF
    Am Rev Respir Dis; 1969 Feb; 99(2):242-8. PubMed ID: 4975012
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross reactivity of lepromin with other mycobacterial antigens.
    Goihman-Yahr M; Raffel S; Ferraresi RW
    Int J Lepr Other Mycobact Dis; 1968; 36(2):129-43. PubMed ID: 4877112
    [No Abstract]   [Full Text] [Related]  

  • 11. [The protective activity of mycobacterial antigens. 3. Protective activity of killed mycobacterial bodies].
    Stavri D; Anagnoste V; Drăghici D
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):91-101. PubMed ID: 4936247
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of Corynebacterium parvum and Freund's adjuvants on amphibian antibody responses.
    Turner RJ; Nguyen-Dang T; Manning MJ
    J Reticuloendothel Soc; 1974 Oct; 16(4):232-8. PubMed ID: 4142047
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenicity of Corynebacterium pseudotuberculosis and the effect of adjuvants in mice.
    Brogden KA; Cutlip RC; Lehmkuhl HD
    J Comp Pathol; 1985 Apr; 95(2):167-73. PubMed ID: 3837788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared antigens between Mycobacterium bovis (BCG) and other bacterial species.
    Minden P; McClatchy JK; Cooper R; Bardana EJ; Farr RS
    Science; 1972 Apr; 176(4030):57-8. PubMed ID: 4621967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant activity of mycobacterial fractions. II. In vitro adjuvant activity of cell walls of mycobacteria, nocardia and corynebacteria.
    Taniyama T; Watanabe T; Azuma I; Yamamura Y
    Jpn J Microbiol; 1974 Nov; 18(6):415-26. PubMed ID: 4616109
    [No Abstract]   [Full Text] [Related]  

  • 16. Structure of Freund's complete and incomplete adjuvants. Relation of adjuvanticity to structure.
    Dvorak AM; Dvorak HF
    Immunology; 1974 Jul; 27(1):99-114. PubMed ID: 4605156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvanticity and strains of mycobacteria.
    Hiu IJ
    Jpn J Exp Med; 1980 Jun; 50(3):183-8. PubMed ID: 7001095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigens and adjuvants.
    White RG
    Proc R Soc Med; 1968 Jan; 61(1):1-6. PubMed ID: 4865787
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of adjuvants on the immunological response of the chicken. I. Effects on primary and secondary responses of various adjuvants in the primary stimulus.
    Steinberg SV; Munro JA; Fleming WA; French VI; Stark JM; White RG
    Immunology; 1970 May; 18(5):635-44. PubMed ID: 4986929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to intracellular infection in mice immunized with Toxoplasma vaccine and adjuvant.
    Ruskin J; Remington JS
    J Reticuloendothel Soc; 1971 May; 9(5):465-79. PubMed ID: 4997287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.